Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $195,972
Award facts
- Contract value 100% obligated
- $195,971.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $195,971.86 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, was executed without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to Department of Defense healthcare facilities, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals such as oncology treatments and immunosuppressants.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) within the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The PPV-G GEN V contract authorizes the DLA to issue firm fixed-price delivery orders for pharmaceutical products and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide, positioning DMS Pharmaceutical Group as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEMMM?
SPE2DU26FEMMM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DU26FEMMM worth?
The government has obligated $195,972 on SPE2DU26FEMMM.
Is contract SPE2DU26FEMMM an order under another contract?
Yes. SPE2DU26FEMMM is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMM competed?
The extent of competition for SPE2DU26FEMMM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award